Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Biopolymers|January 1, 1995
The development of potent peptide agonists and antagonists for the endothelin receptorsW L Cody, A M DohertyThe Journal of Peptide Research : Official Journal of the American Peptide Society|October 17, 1998
The asymmetric synthesis of arginine mimetics: derivatives of (S)-2-, 3- and 4-amidinophenylalanine suitable for incorporation into enzyme inhibitors and/or peptidesD R Kent, W L Cody, A M DohertyJournal of Chromatography|November 30, 1984
Reversed-phase high-performance liquid chromatography studies of alpha-MSH fragmentsW L Cody, B C Wilkes, V J HrubyInternational Journal of Peptide and Protein Research|February 1, 1988
Conformation of D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 (CTP-NH2), a highly selective mu-opioid antagonist peptide, by 1H and 13C n.m.rJ T Pelton, M Whalon, W L Cody, et al.Journal of Biomolecular NMR|January 1, 1994
The 13C chemical shifts of amino acids in aqueous solution containing organic solvents: application to the secondary structure characterization of peptides in aqueous trifluoroethanol solutionV Thanabal, D O Omecinsky, M D Reily, et al.Current Pharmaceutical Design|January 19, 2000
Progress in the development of inhibitors of SH2 domainsW L Cody, Z Lin, R L Panek, et al.Biochemical and Biophysical Research Communications|June 13, 1986
Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2D G Klemes, K L Kreutzfeld, M E Hadley, et al.International Journal of Peptide and Protein Research|June 1, 1986
Comparative biological activities of potent analogues of alpha-melanotropin. Effect of nonaromatic and para substituted aromatic amino acids at position 7B C Wilkes, W L Cody, V J Hruby, et al.Brain Research|October 9, 1995
Permeability of the blood-brain barrier to the neurotensin8-13 analog NT1W A Banks, D J Wustrow, W L Cody, et al.Journal of the American Society of Nephrology : JASN|January 1, 1994
Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin AL S Davis, S J Haleen, A M Doherty, et al.Pageof 4